In partnership, the Bristol Myers Squibb Foundation and National Medical Fellowships have created the Diversity in Clinical Trials Career Development Program (DCTCDP) aimed at increasing diversity in clinical trials.
The goal of the Bristol Myers Squibb Foundation Diversity in Clinical Trials Career Development Program (DCTCDP) is to increase diversity of patients enrolled in clinical trials, and ultimately enhance the development of therapeutics for all populations. The program will collaborate with communities to facilitate an approach to clinical and translational research that is community-informed, designed and conducted. It will provide the sponsorship, support and tools that emerging investigators need to conduct clinical trials that will yield the development of new treatments that are effective in all populations.
The BMSF DCTCDP is a 2-year program designed to support the career development of early-stage investigator (as defined by NIH) physicians underrepresented in medicine, or, physicians who have a demonstrated commitment to increasing diversity in clinical research, to become independent clinical trial investigators who are engaged in advancing health equity through their research and mentoring. The DCTCDP offers a comprehensive and integrated approach to increasing diversity in clinical trials through workforce development and clinical trial site development in underserved communities where underrepresented patients receive care. Additionally, the program will assist program investigators in building capacity and standing up new clinical trials sites in communities with diverse and heavily burdened patient populations.
Clinical research focus areas:
- Cancer (Hematology and Oncology), Cardiovascular Disease and Immunologic Disorders
Deadline: LOIs should be submitted ASAP. If invited for a full application, that deadline is July 2.
Dollar Amount: $120K/year for 2 years; requires at least 40% of the Scholar’s time (Note: Awards will be given to organizations, not to individuals.)
Eligibility: Eligible candidates will hold the degree of MD, MD/PhD, DO or DO/PhD. Eligible candidates will reflect the National Science Foundation (NSF) definition of underrepresented populations in the US Biomedical, Clinical, Behavioral and Social Sciences Research Enterprise OR have a demonstrated commitment to increasing diverse patient participation in clinical trials. Candidates must be an Early Stage Investigator (ESI): As defined by NIH, a new investigator who has completed his or her terminal research degree or medical residency—whichever date is later—within the past 10 years and has not yet competed successfully for a substantial, competing NIH research grant.
Full RFP: https://diversityinclinicaltrials.org